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Abstract
Background: Chest radiographic abnormalities were common in HIV-infected individuals in the pre-combination
antiretroviral therapy era, but findings may differ now due to a changing spectrum of pulmonary complications.
Methods: Cross-sectional study of radiographic abnormalities in an HIV-infected outpatient population during the
antiretroviral therapy era. Demographics, chest computed tomography, and pulmonary function tests were obtained in HIV-
infected volunteers without acute respiratory illness from the University of Pittsburgh HIV/AIDS clinic. Overall prevalence of
radiographic abnormalities and potential risk factors for having any abnormality, nodules, or emphysema were evaluated
using univariate and multivariable analyses.
Results: A majority of the 121 participants (55.4%) had a radiographic abnormality with the most common being
emphysema (26.4%), nodules (17.4%), and bronchiectasis (10.7%). In multivariate models, age (odds ratio [OR] per year
= 1.07, 95% confidence interval [CI] 1.04–1.14, p,0.001), pneumonia history (OR = 3.60, 95% CI = 1.27–10.20, p = 0.016), and
having ever smoked (OR = 3.66, p = 0.013, 95% CI = 1.31–10.12) were significant predictors of having any radiographic
abnormality. Use of antiretroviral therapy, CD4 cell count, and HIV viral load were not associated with presence of
abnormalities. Individuals with radiographic emphysema were more likely to have airway obstruction on pulmonary
function tests. Only 85.8% participants with nodules had follow-up imaging resulting in 52.4% having stable nodules, 23.8%
resolution of their nodules, 4.8% development of a new nodule, and 4.8% primary lung cancer.
Conclusions: Radiographic abnormalities remain common in HIV-infected individuals with emphysema, nodules, and
bronchiectasis being the most common. Age, smoking, and pneumonia were associated with radiographic abnormalities,
but HIV-associated factors did not seem to predict risk.
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Introduction
With advancements in antiretroviral therapy (ART), chronic co-
morbidities of HIV have now become more common as the life
expectancy of those with HIV has increased [1–4]. The spectrum
of lung diseases has changed, with conditions such as chronic
obstructive pulmonary disease (COPD), pulmonary hypertension,
and lung cancer becoming more important in the current HIV-
infected population [5–9].
Prior to the introduction of ART, studies in HIV-infected
individuals reported high prevalence of radiographic abnormalities
such as nodules, ground-glass opacities, and intrathoracic lymph-
adenopathy [10–15]. Many abnormalities were related to either
past or chronic infections in patients with and without respiratory
complaints [16]. Findings on computed tomography (CT) have
been used to accurately diagnose pulmonary complications of
AIDS [15]. During the current era of HIV, radiographic findings
may differ in light of the decreasing incidence of pulmonary
infections, but few studies have re-examined radiographic findings
on chest CT examination in the contemporary population [17].
Given the frequency of chronic respiratory complaints in HIV-
infected populations [18,19] and the high prevalence of CT
scanning [20], understanding radiographic manifestations of HIV
is important for patient care.
We performed a cross-sectional study of radiographic abnor-
malities in an HIV-infected outpatient population without acute
respiratory illness. Pulmonary function testing was also performed
to determine the relationship between visual assessment of CT
exams and physiologic measurements of COPD [21–23]. The
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objective of the study was to assess the prevalence and nature of
radiographic abnormalities on chest CT examinations in an HIV-




Participants were recruited from the University of Pittsburgh
HIV/AIDS Clinic. All participants were recruited from an
outpatient clinic setting and were not admitted inpatient to a
hospital. Details of this cohort have been previously reported [24].
Individuals with documented HIV infections who were 18 years of
age or older were recruited from the clinic between July 1, 2007
and September 30, 2010. Participants were able to have chronic
respiratory symptoms such as a chronic cough but were excluded if
they had an acute change in these symptoms such as worsening
cough, increased shortness of breath, etc. within the previous 4
weeks of their visit date. The chronic respiratory symptoms
queried in our survey included details about cough, phlegm
production, wheezing, and shortness of breath. Individuals were
excluded if they reported acute change in respiratory symptoms or
fever in the 4 weeks prior to study entry or had contraindication to
performing chest CT scan or pulmonary function tests (PFTs).
Patients were able to have chronic respiratory symptoms such as a
chronic cough phlegm production, wheezing, and shortness of
breath. Written informed consent was obtained, and the
University of Pittsburgh Institutional Review Board approved
the protocol.
Data collection
Demographic and clinical data were obtained during partici-
pant interviews and review of medical record. Collected data
included age, gender, smoking history, intravenous drug use
(IVDU), self-report of pneumonia history, and self-report of
current use of antiretrovirals. Extensive smoking history was
obtained for any participant that was ever a smoker, which was
defined as having smoked more than 100 cigarettes in their
lifetime. Information regarding IVDU history, marijuana use, or
crack cocaine use was obtained by self-report of ever user, use
within 6 months prior to study date, and use within one week prior
to study date. Medical records from within 6 months preceding the
study were reviewed to record the most recent CD4+T-lympho-
cyte cell count and plasma HIV-RNA levels of participants. All
participants answered a standardized respiratory questionnaire
[25].
Chest computed tomography
Non-contrasted CT scans were acquired at 100 mAs and
reconstructed using both the GE ‘‘bone’’ and ‘‘standard’’ kernels
at 0.625 mm thickness at end-inspiration. Chest CT scans were
performed for research purposes, not clinical indications. Using
standardized definitions [26], each CT scan was visually reviewed
and rated by a radiologist and a pulmonologist. Each reader was
blinded to participant characteristics. In cases of differing CT scan
interpretation, a third reader reviewed the CT scans in order to
resolve discrepancies. Radiographic abnormalities were defined as
presence of bulla, cysts, nodules, bronchiectasis, ground glass
opacities, emphysematous changes, pleural disease, consolidation,
honeycombing, mosaic attenuation, and reticular abnormality. To
quantify the presence of emphysema, the percentage of the lung
voxels associated with emphysema was computed using the density
mask technique [27].
Pulmonary function testing
Participants performed pre- and post-bronchodilator spirometry
according to standard American Thoracic Society (ATS) standards
[28]. Spirometry predicted values were calculated by Hankinson
equations [29]. Neas prediction equations were used to calculate
diffusing capacity for carbon monoxide (DLCO) with adjustments
for hemoglobin and carboxyhemoglobin levels obtained at time of
pulmonary function testing [30].
Statistical analysis
Prevalence of each radiographic abnormality was determined,
and risk factors for having any defined abnormality were evaluated
using univariate and multivariable analyses. Variables were
transformed as necessary to approximate normality. Because
non-calcified nodules and emphysema were common and
clinically important, in-depth analyses of each of these findings
were also performed. For nodules, we determined the median
number and size of nodules. For visually assessed emphysema, we
determined distribution, extent (scoring 0=,5%, 1= 5–10%,
2= 11–25%, 3= 26–50%, 4= 51–75%) and type of emphysema
(panacinar, centrilobular, etc.). Bivariate analysis of factors
associated with nodules or emphysema was performed using t-
tests, rank sum test, chi-square, or Fisher’s exact. The relationship
of visually assessed emphysema to pulmonary function variables
including forced expiratory volume in one second (FEV1) percent
predicted, forced vital capacity (FVC) percent predicted, FEV1/
FVC ratio, and DLco percent predicted were determined using t-
tests. The percentage of the lung voxels less than -910 Hounsfield
units (HU) and less than -950 HU was evaluated in relation to
presence of any emphysema using t-tests or rank-sum.
Results
Description of cohort
A total of 121 participants were included in the analysis. The
majority (67.8%) was male (Table 1). Average age was 45.1 years
with a range from 21–72 years. The majority of participants
(85.1%) were currently taking ART and median time of HIV
infection was 15.8 years with a range = 1.60–29.6 years. There
was a predominance of smokers (80.2%) and only 4 participants
reported ever using intravenous drugs. About a quarter (23.1%) of
the sample reported having had at least one prior episode of
pneumonia requiring treatment and a smaller percentage reported
a history of TB (9%). No participants had a history of pleural
effusion.
Radiographic abnormalities
A majority of participants (55.4%) had a visually detected
abnormality on chest CT exam (Figure 1). Overall, emphysema
was the most common finding (26.4%) (Figure 2) followed by
nodules (17.4%). Bronchiectasis and ground glass opacities were
also fairly common (10.7% and 8.3% respectively). None of the
participants had evidence of adenopathy, consolidation, mosaic
perfusion, or honeycombing. Overall, a third reviewer was needed
to resolve discrepancies on average 6.9% of cases with the most
common discrepancies in question being the presence of
bronchiectasis (17.4%), ground glass opacities (15.7%), and
emphysema (14.0%).
Predictors of any abnormality
Individuals with an abnormality on CT scan were significantly
older on average than those without abnormalities (47.2 years
versus 42.5 years, p,0.001), significantly more likely to have
smoked in the past, and significantly more likely to have a history
Chest CT in HIV in the ART Era
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of previous pneumonia (Table 1). Only one participant reported
known history of Pneumocystis pneumonia, so this was not
included as a predictor. Subjects with abnormalities on CT
examination were more likely to have an undetectable HIV viral
level, but this relation was not statistically significant. There was no
relationship of CD4 cell count to presence of abnormalities.
Subjects with visualized abnormalities on CT chest were not
significantly more likely to have chronic respiratory complaints
such as chronic cough, phlegm, wheezing, and shortness of breath.
In multivariate models, age (odds ratio [OR] =1.07 for every year
increase, 95% confidence interval [CI] 1.04–1.14, p,0.001) and
having smoked (OR =3.66, p = 0.013, 95% CI =1.31–10.12)
were significant predictors of a radiographic abnormality.
Nodules
Pulmonary nodules were common (17.4%). The majority of
participants with nodules had a solitary nodule (range of number
of nodules = 1–14). Median length of the long axis of nodules was
6 mm (range 2–30 mm). Smokers were somewhat more likely to
have nodules (19.6% versus 8.3% of non-smokers, p = 0.19), and
individuals with nodules tended to have visualized emphysema
(25.0% with emphysema versus 14.6% without nodules, p = 0.18),
but neither comparison reached significance. Of those participants
with pulmonary nodules, 14.2% did not obtain follow-up. Of
participants who underwent follow-up chest CT exam, 52.4% had
stable nodules without a specific diagnosis or additional work-up
and 23.8% had resolution of their nodules. One participant out of
the cohort was diagnosed with primary lung cancer during the
timeframe of our study. On average, the length between initial and
follow-up chest CT exam was 17 months.
Analyses of emphysema
Most participants with emphysema on visual assessment had
upper lobe disease (n = 25, 78.1%), but mid- and lower lung
emphysema was also common, seen in 56.3% and 40.6%,
respectively. No participants had pan-lobular emphysema. The
majority of subjects with emphysema on visual assessment had
mild emphysema (1–10% of lung involvement). Subjects with
visually assessed emphysema were significantly older, more likely
to have smoked, and somewhat more likely to have ever used
intravenous drugs. They were not more likely to report chronic
respiratory complaints such as chronic cough, phlegm, wheezing,
and shortness of breath (data not shown). Multivariate models of
risk factors for emphysema demonstrated that age (OR =1.15 for
every year increase, p,0.001, 95% CI =1.07–1.24) and having
smoked (OR =29.1, p = 0.006, 95% CI =2.68–315.18) were
significant independent predictors of emphysema.
Table 1. Description of Cohort and Relationship of Clinical Variables to Radiographic Abnormalities, n = 121.
Characteristic Without abnormality n =54 With abnormality n=67 p-value ,0.05
Male, n (%) 82 (67.8) 28 (51.9) 54 (80.6) 0.480
Age, mean years (SD) 45.1 (9.8) 42.5 (9.1) 47.2 (9.9) 0.009
African-American, n (%) 54 (44.6) 28 (51.8) 26 (41.8) 0.480
Ever smoker, n (%) 97 (80.2) 38 (70.3) 59 (88.1) 0.015
Currently taking ART, n (%) 103 (85.1) 43 (79.6) 60 (89.6) 0.127
CD4 count, median cells/ml (range) 537 (24–1798) 520 (21–1798) 561 (24–1493) 0.913
Viral load, median copies/ml (range) 49 (49–1,960,000) 49 (49–1,960,000) 49 (49–522,000) 0.098
IVDU, n (%) (of 101) 4 (4.0) 0 (0) 4 (6.0) 0.073
Previous pneumonia, n (%) 28 (23.1) 8 (14.8) 20 (29.9) 0.046
n= number, SD = standard deviation, ART = anti-retroviral therapy, IVDU = intravenous drug us.
doi:10.1371/journal.pone.0112237.t001
Figure 1. Frequency of radiographic abnormalities visualized
among all participants. None of the participants had evidence of
consolidation, mosaic perfusion, or honeycombing.
doi:10.1371/journal.pone.0112237.g001
Figure 2. Selected CT image showing emphysema in HIV
patient.
doi:10.1371/journal.pone.0112237.g002
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Individuals with visually assessed radiographic emphysema were
more likely to have airflow obstruction and decreased DLco
(Figure 3). They also had more quantitative emphysema as
measured by either percentage of lung below -910 or -950 HU
(Figure 4). Medical record review of participants with any visually
assessed emphysema revealed only 24% had been diagnosed with
COPD by ICD-9 code.
Discussion
Our study evaluates the prevalence and spectrum of abnormal-
ities on chest CT examination in an HIV-infected population in
the current ART era. A majority of participants were found to
have a radiographic abnormality; emphysema, nodules, and
bronchiectasis were the most common. No adenopathy was
present among our participants which may reflect that our cohort
is relatively healthy given the study is limited to an outpatient
population that regularly engages in healthcare with a designated
HIV clinic. Significant predictors of any radiographic abnormality
were age or tobacco exposure. HIV-specific predictors such as
CD4 cell count and HIV viral level were not significantly
associated with radiographic abnormalities.
Overall, our study population had a strikingly high prevalence
of radiographic abnormalities, although no HIV-uninfected
control group was available for comparison. Various studies done
prior to the ART era also showed chest radiographic abnormal-
ities were common in HIV-infected populations [11–15]. One
study from the pre-ART era that examined a cohort of AIDS
patients referred for chest CT examination found that 72% had
active disease with Pneumocystis pneumonia, Kaposi sarcoma,
tuberculosis, and pyogenic or fungal infections being the most
common diagnoses [15]. Diseases were characterized by CT
image findings such as ground glass opacities in patients with
Pneumocystis or peribronchovascular nodules with Kaposi sarco-
ma [14,15]. In contrast, our study found emphysema and nodules
to be the most common abnormalities. This difference illustrates
the changing trend of pulmonary disease in HIV-infected
populations from acute infection to chronic conditions. Of note,
these pre-ART studies were comprised mostly of participants who
had AIDS and did not specifically evaluate emphysema.
HIV-associated variables may be related to chest CT scan
findings. Prior to the ART era, CD4 cell counts ,200 combined
with intrathoracic lymphadenopathy on imaging predicted Kaposi
sarcoma, mycobacterial diseases, and Pneumocystis pneumonia
[31]. In a follow-up study, no association was found between CD4
cell count and pulmonary nodules possibly because the majority of
the study population had low CD4 counts [12]. In contrast, our
participants were outpatients, had chest CT examinations
performed electively as part of a research study, and had high
CD4 cell counts. We found no relationship between CD4 count
and radiographic abnormalities.
Nodules are common and clinically important given the
increase in lung cancer rates in HIV-infected populations
[32,33]. Prior to the ART era, nodules on chest CT examination
were most likely due to cancer, tuberculosis, or Kaposi sarcoma
[12,15]. Follow-up imaging in most of our study’s participants
showed stable nodules, and only one participant underwent
biopsy. Diagnoses in our study include inflammation due to
bronchiolitis, unknown etiology, and adenocarcinoma. In a study
that examined abnormal CXR findings in HIV-infected popula-
tions, abnormal imaging led to invasive diagnostic testing of 79%
of participants [16]. Many of the patients in that study, as in our
study, did not have acute respiratory symptoms (CXR had been
done for non-pulmonary complaints, constitutional symptoms,
screening for incarceration), but were found to have occult
opportunistic infections. Fewer opportunistic infections in the
ART era likely contribute to the tendency for nodules in our
cohort to be stable and chronic. Although most nodules were
stable over the time period of the study, it is not known if they
might eventually be diagnosed as malignant as we may have
insufficient length of follow-up. Also, almost 15% did not have
further evaluation of their nodules despite recommendations,
limiting ability to determine a diagnosis.
The frequency of nodules in this population could have
implications for determining utility of lung cancer screening. We
did not have an HIV-uninfected group for comparison, but in the
general population in our cohort’s geographical region, a similar
frequency of nodules found on CT imaging has been reported in a
study of participants who are former and current smokers [34,35].
Trials have shown screening for lung cancer using chest CT
reduces mortality from lung cancer among smokers deemed at
high risk [35,36]. Given lung cancer tends to be diagnosed at more
advanced stages and at a younger age in those infected with HIV
[37], separate studies are necessary to establish specific guidelines
for screening of HIV-infected populations. One such recent study
compared potential harm versus benefit of the use of low dose CT
scan for lung cancer screening between asymptomatic HIV-
infected and uninfected groups [17]. The study did not find an
increased rate of abnormalities leading to follow-up testing in
HIV-infected patients, though it did identify that those with CD4
counts,200 may be more likely to have false positive findings and
potentially unnecessary invasive testing [17].
Similar to studies in the pre-ART era, emphysema was common
in our cohort. Centrilobular emphysema was most common, and
the degree of radiographic emphysema was mild, although
emphysema might be greater in an older HIV-infected cohort.
Although it is difficult to compare different populations, a pre-
ART study found a somewhat lower prevalence of radiographic
emphysema of 15%, suggesting that emphysema may now be
more common [37]; however, pre-ART cohort participants were
on average 10 years younger and had less smoking prevalence
when compared to the current study, which may also explain this
difference. While we were not able to compare our study
population to an HIV-uninfected group, the pre-ART study also
reported an incidence of emphysema on 2% of the CT exams in
their HIV-uninfected participants. A prevalence of emphysema of
42.5% was found among subjects in a more recent study
examining high-risk populations due to a substantial smoking
exposure history [38].
Age and smoking predicted presence of emphysema, but HIV-
associated factors did not correlate with evidence of emphysema
Figure 3. Percentage of Individuals with visually assessed
radiographic emphysema. FEV1 = forced expiratory volume; FVC =
forced vital capacity; DLCO = diffusing capacity for carbon monoxide.
doi:10.1371/journal.pone.0112237.g003
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on CT exam. This finding is consistent with prior results that
showed no difference in number of participants with COPD
between those taking or not taking ART [8]. Radiographic
findings of emphysema correlated with PFT evidence of obstruc-
tive disease and reduced DLco. Only a quarter of the participants
with visualized emphysema had been diagnosed with COPD,
suggesting that emphysema is likely under-diagnosed in HIV-
infected individuals and possibly missed as an important risk factor
for lung cancer.
Limitations of the study included that it was a single cohort, had
a high prevalence of smoking, antiretroviral therapy use was
measured by self-report, pneumonia history was by self-report, and
the study lacked an HIV-uninfected control group. Patients
enrolled in the study obtain their medical care in different settings
making it difficult to verify our facility medical record contains
every episode of pneumonia for a given patient. Lack of power
may have affected the significance for various associations with
radiographic findings. The high prevalence of smoking among the
cohort may limit the generalizability of the prevalence of different
findings to similar populations, but many HIV-infected groups
have a high prevalence of smoking. Intravenous drug use was also
relatively uncommon in our cohort, which might also influence the
types of abnormalities seen. Although we saw no association of
abnormalities with or without ART use, we did not capture
individuals starting ART who might have a different spectrum or
prevalence of radiographic findings.
We have found that radiographic abnormalities remain
common in HIV-infected individuals with emphysema and
nodules being the most common findings of clinical relevance.
In this outpatient cohort, age and smoking were associated with
radiographic abnormalities, but HIV-associated factors such as
CD4 cell count and viral load were not associated with
radiographic abnormalities. Nodules were a frequent finding,
and most were stable or resolved without diagnostic or therapeutic
intervention. Our findings indicate that emphysema is common in
HIV-infected populations and that visually assessed emphysema
strongly correlated with quantitatively assessed emphysema and
with lung function.
Some results were previously presented in the form of a poster at
the May 2011 American Thoracic Society International Confer-
ence in Denver, CO.
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